Foster Wheeler acquires Yonkers Industries

Foster Wheeler has acquired Yonkers Industries, a US firm that specialises in the management of construction and commissioning of pharmaceutical and biotech facilities. No financial details have been revealed.

The move provides the global engineering and construction firm, which is headquartered in Geneva, Switzerland, with a construction management capability in North America.

With offices in California, North Carolina and Puerto Rico, Yonkers Industries employs around 200 people. Through its participation in a project-services partnership called Modular Partners, Yonkers also has the ability to provide modular project delivery services on a worldwide basis.

The purchase provides Foster Wheeler with a construction management capability in North America

‘Yonkers has a global reputation for excellence in contract execution, and the addition of this construction management capability immediately strengthens our value proposition to pharmaceutical and biotech clients,’ said Kent Masters, CEO of Foster Wheeler.

‘Foster Wheeler Biokinetics, our US-based pharmaceutical unit, will experience the most immediate benefit from this acquisition – as the client portfolios and geographic coverage of the two companies fit together quite effectively. We believe that the project and construction management skills of Yonkers are a perfect complement to the biotech engineering expertise of Biokinetics.’

Foster Wheeler employs approximately 12,000 people. The company’s Global Engineering and Construction Group designs and constructs processing facilities for the pharmaceuticals, biotechnology and healthcare industries, as well as for upstream oil and gas, LNG and gas-to-liquids, and the refining, chemicals and petrochemicals, power, mining and metals, and environmental sectors. Its Global Power Group is a leader in combustion and steam generation technology that designs, manufactures and erects steam generating and auxiliary equipment for power stations and industrial facilities.